It's the sixth recall of Motrin in two years.
Kensey Nash withdraws guidance; shares plummet.
A Novartis' vaccine facility in North Carolina today became the first facility authorized by the FDA for emergency use during a pandemic.
Some senators are concerned that Pfizer's deals with pharmacy benefit managers will undermine the sale of generic versions of Lipitor.
The pharma sells U.S. rights for the migraine drug to Canada's national pension fund.
Safeguard Scientifics recognizes the increasing crossover between health-care services and IT.
For pharmaceuticals distributor Cardinal Health, China represents a world of opportunity.
GSK said the settlement will reduce financial uncertainty for the company and is in the best interest of shareholders.
Invacare looks to other markets to counter "slowness" in the industry.
Will "Watson" revolutionize health care? How?
The supercomputer will help doctors, not replace them, as one IBM official sees it.
If at first you don't succeed...
Duke and Verizon will also form a scientific advisory board staffed with representatives from both partners.
The company looks to get in tune with social media.
The conversation between sales reps and doctors today is vastly different compared to one year ago.
Is this Roche Blockbuster good news for LabCorp, too?
GSK defends its patents.
The nuclear medicine business is an important driver of higher margins for the drug distribution company.
News from GlaxoSmithKline.
There's a deadline.